China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.56% | 6.46% | -87.58% | -23.30% | 32.74% |
| Total Depreciation and Amortization | 16.54% | 71.13% | 60.96% | 10.94% | -2.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 678.57% | 99.99% | -12,596.52% | -48.39% | -0.24% |
| Change in Net Operating Assets | 152.44% | -99.25% | 28,539.57% | -118.80% | 58.48% |
| Cash from Operations | 40.69% | -136.38% | 164.14% | -186.40% | 472.18% |
| Capital Expenditure | -- | -- | 16.67% | -700.00% | 100.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 86.75% | -- | -- |
| Cash from Investing | -- | -- | 85.71% | -40,700.00% | 100.17% |
| Total Debt Issued | -- | -- | 195.60% | -174.49% | -- |
| Total Debt Repaid | 45.40% | 89.84% | -226.25% | 160.82% | -1,223.05% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 251.45% | -9.23% | 40.59% | -445.54% | 70.83% |
| Foreign Exchange rate Adjustments | 216.90% | -1,176.92% | -90.80% | 207.07% | -633.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 177.24% | -327.87% | 121.68% | -268.35% | 199.11% |